TABLE 1.

DLS dimensions of NPs size (nm) and potential (mV) and the inhibition zone (mm) of the biogenic NPs as well as the antibiotics tested against different microbes.

Nano material	DLS Mean ± S.D. (nm)	Zeta Potential (m V)	Inhibition Zone Mean ± S.D. (mm)				IC50
			E. coli	S. aureus	P. aeruginosa	C. albicans	MDA-MB-231 cells (μg/mL)
An-AgNPs	114 ± 2.04	−1.2	23.6 ± 3.8	22.4 ± 0.4	23.6 ± 0.2	14.8 ± 0.2	149.2
Ar-AgNPs	125.5 ± 2.5	−0.4	16.8 ± 0.5	16.4 ± 0.7	24.7 ± 0.3	0	585.2
An ions			15.8 ± 1.3	11.7 ± 0.7	24.4 ± 1.2	16.2 ± 2.2
Bacitracin			0	6 ± 0	0	0
Tetracycline			0	10 ± 0	15 ± 0	0
Cefixime			0	10 ± 0	6 ± 0	0
Ciprofloxacin			0	7 ± 0	35 ± 0	0
Fluconazole			–	–	–	46.2 ± 0
Metronidazole			–	–	–	15 ± 0

Data represent the mean ± standard deviation of the mean (SD) of three independent experiments.